arrow
J

Jie Huang

xuzhou medical university
H指数:26
被引数:2,178

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
2024-05-020
PRE
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial

未经治疗的晚期非小细胞肺癌患者sintilimab与pembrolizumab联合或不联合铂类双重化疗的PD-L1表达指南 (CTONG1901): 一项2期随机对照试验

2024-02-016
OAAI
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
2023-07-2421
PRE